Page last updated: 2024-11-08

ardisiacrispin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ardisiacrispin A: utero-contracting oleanane triterpene saponin from Ardisia crispa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Ardisia crispaspecies[no description available]PrimulaceaeA plant family of the order ERICALES, class MAGNOLIOPSIDA, with flowers having both stamens and pistil, producing encapsulated fruits.[MeSH]

Cross-References

ID SourceID
PubMed CID168133
MeSH IDM0154322

Synonyms (4)

Synonym
ardisiacrispin a
3beta-o-(beta-d-xylopyranosyl-(1-2)-o-beta-d-glucopyranosyl-(1-4)-(o-beta-d-glucopyranosyl-(1-2))-alpha-l-arabinopyranosyl)-16alpha-hydroxy-13beta,28-epoxyolean-30-al
oleanan-29-al, 13,28- epoxy-3-((o-beta-d-glucopyranosyl-(1-2)-o-(o-beta-d-xylopyranosyl-(1-2)-beta-d-glucopyranosyl-(1-4))-alpha-l-arabinopyranosyl)oxy)-16-hydroxy-, (3beta,16alpha,20beta)-
D85156

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]